Cannabidiol Lacks Direct Effect on Cortical Excitability: A Randomized, Double Blind, Placebo Controlled, 3-Way Crossover Trial Abstract Cannabidiol (CBD) is approved as an adjunctive treatment of seizures associated with Dravet syndrome, Lennox– Gastaut Syndrome, and tuberous sclerosis. Its therapeutic and adverse effects are... Epilepsy Neuromodulation TMS-EEG waveguard Aug 20, 2025 Publication
Repetitive Transcranial Magnetic Stimulation for the Treatment of Focal Drug-Resistant Epilepsy: A Crossover, Randomized, Single-Blinded, Sham-Controlled Clinical Trial Abstract Objective To evaluate the efficacy and safety of low-frequency repetitive transcranial magnetic stimulation (LF rTMS) in patients with focal drug-resistant epilepsy (DRE) using a randomized, ... EEG Epilepsy Neuronavigation visor2 Jul 27, 2025 Publication